glp-1 drug tirzepatide People Can Lose Their Zest for Life After Starting GLP-1s, Docs Warn Tirzepatide Associated with Lower POAG,
Description
Those who used a GLP-1 receptor agonist for 1 to 3 years (aHR = 1.58

Vision changes GLP-1s can affect the vision in several ways, including worsening vision in some cases due to rapid blood sugar correction or insufficient blood flow to the optic nerve

Nonetheless, subsequent evidence indicating that the insulinstimulating effect of GIP is partially regained through enhanced glycemic management in T2DM subjects [129, 130], coupled with the emergence of new antagonists [131] suitable for clinical investigations, is prompting a reevaluation of the involvement of GIP in moderating the DPP4i treatment glycemic effects

10.2337/dc19-S009 [DOI] [PubMed] [Google Scholar] 19.Gallwitz B

2018;378(25):e34
